Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 4 | 2022 | 85 | 2.420 |
Why?
|
| Familial Hypophosphatemic Rickets | 3 | 2023 | 4 | 2.380 |
Why?
|
| Bone Density | 14 | 2023 | 152 | 2.320 |
Why?
|
| HIV Infections | 6 | 2023 | 888 | 2.200 |
Why?
|
| Bone Matrix | 4 | 2017 | 28 | 2.070 |
Why?
|
| Bone and Bones | 9 | 2023 | 126 | 1.930 |
Why?
|
| Animals | 27 | 2023 | 4720 | 1.400 |
Why?
|
| Biomarkers | 8 | 2022 | 734 | 1.360 |
Why?
|
| X-Ray Microtomography | 10 | 2023 | 81 | 1.260 |
Why?
|
| Osteolysis | 5 | 2019 | 147 | 1.250 |
Why?
|
| Bone Remodeling | 4 | 2021 | 46 | 1.240 |
Why?
|
| Osteocalcin | 5 | 2022 | 23 | 1.210 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 13 | 1.210 |
Why?
|
| Parathyroid Hormone | 3 | 2021 | 24 | 1.170 |
Why?
|
| Glycoproteins | 3 | 2018 | 59 | 1.120 |
Why?
|
| Implants, Experimental | 3 | 2021 | 32 | 1.090 |
Why?
|
| Mice | 11 | 2023 | 1681 | 0.930 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 164 | 0.920 |
Why?
|
| Tooth | 1 | 2023 | 1 | 0.910 |
Why?
|
| Osseointegration | 3 | 2021 | 77 | 0.890 |
Why?
|
| Fractures, Bone | 2 | 2022 | 81 | 0.860 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 12 | 0.850 |
Why?
|
| Bone Development | 1 | 2023 | 37 | 0.840 |
Why?
|
| Joint Prosthesis | 2 | 2020 | 81 | 0.800 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 60 | 0.770 |
Why?
|
| Lactation | 2 | 2018 | 63 | 0.740 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 4 | 0.740 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 7 | 0.740 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 83 | 0.730 |
Why?
|
| Female | 16 | 2023 | 17017 | 0.690 |
Why?
|
| Bone Regeneration | 5 | 2021 | 76 | 0.650 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 8 | 0.640 |
Why?
|
| Weaning | 1 | 2018 | 5 | 0.640 |
Why?
|
| Minerals | 1 | 2018 | 5 | 0.640 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 467 | 0.640 |
Why?
|
| Male | 20 | 2023 | 16499 | 0.610 |
Why?
|
| Osteogenesis | 4 | 2021 | 107 | 0.610 |
Why?
|
| Titanium | 2 | 2021 | 196 | 0.610 |
Why?
|
| Rats | 10 | 2021 | 871 | 0.590 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 2 | 0.550 |
Why?
|
| Phosphates | 3 | 2021 | 21 | 0.530 |
Why?
|
| Humans | 22 | 2023 | 31073 | 0.520 |
Why?
|
| Mutation | 1 | 2016 | 409 | 0.470 |
Why?
|
| Antibodies | 1 | 2014 | 67 | 0.470 |
Why?
|
| Calcitonin | 1 | 2014 | 15 | 0.460 |
Why?
|
| Fracture Fixation | 1 | 2014 | 25 | 0.460 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 14 | 0.460 |
Why?
|
| Diphosphonates | 1 | 2014 | 16 | 0.460 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 12 | 0.460 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 83 | 0.430 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 286 | 0.400 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 59 | 0.380 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 2 | 2021 | 3 | 0.370 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 8 | 0.370 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 2137 | 0.370 |
Why?
|
| Femur | 5 | 2021 | 402 | 0.360 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 115 | 0.360 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 862 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 80 | 0.340 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 19 | 0.340 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 32 | 0.340 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 260 | 0.330 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 1095 | 0.320 |
Why?
|
| Prosthesis Failure | 3 | 2020 | 541 | 0.320 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.280 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 9 | 0.270 |
Why?
|
| Arthroplasty, Replacement | 2 | 2020 | 150 | 0.270 |
Why?
|
| Skull | 2 | 2015 | 26 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 24 | 0.230 |
Why?
|
| Periodontal Ligament | 1 | 2023 | 1 | 0.230 |
Why?
|
| Calcium | 2 | 2018 | 503 | 0.220 |
Why?
|
| Biomechanical Phenomena | 3 | 2020 | 700 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 16 | 0.210 |
Why?
|
| Osteocytes | 2 | 2019 | 15 | 0.210 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 171 | 0.200 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 44 | 0.200 |
Why?
|
| Hypogonadism | 1 | 2021 | 7 | 0.200 |
Why?
|
| Emtricitabine | 1 | 2021 | 4 | 0.200 |
Why?
|
| Infertility | 1 | 2021 | 8 | 0.200 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 20 | 0.200 |
Why?
|
| Femur Neck | 1 | 2021 | 18 | 0.190 |
Why?
|
| Rats, Zucker | 1 | 2021 | 11 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1006 | 0.190 |
Why?
|
| Ovariectomy | 1 | 2021 | 27 | 0.190 |
Why?
|
| Collagen Type I | 1 | 2021 | 22 | 0.190 |
Why?
|
| Cartilage | 1 | 2022 | 159 | 0.190 |
Why?
|
| Azepines | 1 | 2021 | 6 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2021 | 8 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2021 | 21 | 0.190 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 145 | 0.190 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 37 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 782 | 0.180 |
Why?
|
| Triazoles | 1 | 2021 | 34 | 0.180 |
Why?
|
| Plasmids | 3 | 2015 | 45 | 0.180 |
Why?
|
| Viral Load | 1 | 2021 | 196 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2021 | 78 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2021 | 172 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 555 | 0.170 |
Why?
|
| HIV-1 | 1 | 2023 | 459 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 120 | 0.170 |
Why?
|
| Body Weight | 1 | 2019 | 141 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2017 | 77 | 0.170 |
Why?
|
| Collagen | 2 | 2016 | 104 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 68 | 0.160 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.160 |
Why?
|
| Syndactyly | 1 | 2018 | 2 | 0.160 |
Why?
|
| Anabolic Agents | 1 | 2018 | 6 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 104 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 1317 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 156 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2018 | 499 | 0.150 |
Why?
|
| Pregnancy | 1 | 2018 | 404 | 0.140 |
Why?
|
| Cortical Bone | 1 | 2017 | 7 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 36 | 0.140 |
Why?
|
| Prevalence | 1 | 2018 | 499 | 0.140 |
Why?
|
| Comorbidity | 1 | 2018 | 508 | 0.140 |
Why?
|
| X-Rays | 1 | 2016 | 4 | 0.140 |
Why?
|
| Point Mutation | 1 | 2016 | 31 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 695 | 0.130 |
Why?
|
| Middle Aged | 2 | 2021 | 10240 | 0.130 |
Why?
|
| RNA | 1 | 2015 | 38 | 0.130 |
Why?
|
| Prognosis | 1 | 2018 | 924 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2018 | 718 | 0.130 |
Why?
|
| Independent Living | 1 | 2018 | 321 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2016 | 301 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 47 | 0.130 |
Why?
|
| Phenotype | 1 | 2016 | 380 | 0.120 |
Why?
|
| Genotype | 1 | 2016 | 428 | 0.120 |
Why?
|
| Copper | 1 | 2014 | 16 | 0.120 |
Why?
|
| Chitosan | 1 | 2014 | 5 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2015 | 322 | 0.120 |
Why?
|
| Diaphyses | 1 | 2014 | 4 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 81 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 18 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 463 | 0.120 |
Why?
|
| Microvessels | 1 | 2014 | 17 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 48 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 26 | 0.120 |
Why?
|
| Fracture Healing | 1 | 2014 | 41 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 49 | 0.120 |
Why?
|
| Aged | 2 | 2018 | 10082 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 91 | 0.120 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 25 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1134 | 0.120 |
Why?
|
| Thiophenes | 1 | 2014 | 13 | 0.120 |
Why?
|
| Joints | 1 | 2014 | 99 | 0.120 |
Why?
|
| Models, Animal | 1 | 2014 | 130 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 8950 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 90 | 0.110 |
Why?
|
| Corpus Striatum | 1 | 2014 | 99 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 6 | 0.110 |
Why?
|
| Methamphetamine | 1 | 2014 | 48 | 0.110 |
Why?
|
| Cognition | 1 | 2022 | 1428 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2014 | 97 | 0.110 |
Why?
|
| Humerus | 1 | 2014 | 103 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 387 | 0.110 |
Why?
|
| Tibia | 1 | 2014 | 274 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2022 | 81 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 820 | 0.100 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 48 | 0.090 |
Why?
|
| DNA | 3 | 2015 | 124 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5197 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 21 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 270 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 523 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 204 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 696 | 0.070 |
Why?
|
| Cell Survival | 2 | 2015 | 164 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 93 | 0.060 |
Why?
|
| Lamivudine | 1 | 2023 | 22 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 99 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 61 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2022 | 23 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2021 | 36 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 19 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 45 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 25 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 36 | 0.050 |
Why?
|
| Proteins | 1 | 2021 | 73 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 271 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 135 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 133 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1507 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 833 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 121 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 59 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 31 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 105 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 177 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3810 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 132 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 370 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 19 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 10 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 59 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 37 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 9 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 25 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 17 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 35 | 0.030 |
Why?
|
| Corrosion | 1 | 2014 | 135 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 173 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 63 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 103 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 127 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 63 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 118 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 428 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 239 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 509 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 2591 | 0.020 |
Why?
|